-+ 0.00%
-+ 0.00%
-+ 0.00%

ZENAS BIOPHARMA ANNOUNCES SUBMISSION OF BIOLOGICS LICENSE APPLICATION (BLA) TO U.S. FDA FOR OBEXELIMAB IN IGG4-RD

Reuters·05/28/2026 11:05:00

Please log in to view news